NeOnc Technologies Holdings financials
$3.30+4.43%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 |
|---|---|
| Revenue | $40.0K |
| Gross profit | $40.0K |
| Gross margin | 100.0% |
| Operating income | -$58.2M |
| Net income | -$62.1M |
| Net margin | −155404.4% |
| Diluted EPS | $-3.20 |
| EBITDA | -$58.2M |
| Operating cash flow | -$20.4M |
| Free cash flow | -$20.9M |
| Diluted shares | 19.4M |
Balance sheet
| Period end | Dec 31 |
|---|---|
| Cash & equivalents | $58.7K |
| Short-term investments | $0.00 |
| Total debt | $6.0M |
| Total assets | $2.8M |
| Total liabilities | $20.3M |
| Shareholders' equity | -$17.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology